Dr. Brian Lee McClune, DO

Dr. McClune practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. McClune's NPI, 1649296880, was assigned on July 14, 2006. Dr. McClune graduated from Kansas City College of Medicine and Surgery in 2000. Dr. McClune holds Utah license 11448582-1204.

Dr. McClune's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. McClune's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. McClune is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. McClune to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McClune practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. McClune's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McClune is licensed in Utah.

CMS data shows 1,510 Medicare services from Dr. McClune across 8 procedure codes in 2024, for 148 Medicare patients. Medicare paid $70,732 for them.

CMS counts 148 Medicare patients who saw Dr. McClune in 2024. The largest group is 65 to 74, with 83 patients. 70% of them have high blood pressure, and 55% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McClune's median patient age at 71, with 40% women.

In 2024, Dr. McClune wrote 866 Medicare Part D claims for 112 patients. 61% of them were for generic drugs. CMS names the drug for 664 of them, across 15 drugs with 11 or more claims each, at $3,875,447 in total drug cost. In 2023, CMS named 499 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McClune for performance year 2024, reported as part of a group. Dr. McClune accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McClune as offering telehealth.

Dmand AI links 49 papers to Dr. McClune, published from 2010 to 2024. 2020 was the busiest year, with 10. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Transplantation, Homologous. Dr. McClune has published most often in Leuk Lymphoma. Dr. McClune's most frequent co-authors are Saqib Hussen Abbasi, MD, Siddhartha Ganguly, MD and Amandeep Godara, MD.

Dmand AI links Dr. McClune to 4 clinical trials. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Carcinoma, Embryonal. Masonic Cancer Center, University of Minnesota sponsors the most, 2.

CMS Open Payments shows 30 general payments to Dr. McClune from 11 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 55% of the total. National Marrow Donor Program paid the most, $3,998.

Dr. McClune graduated from Kansas City College of Medicine and Surgery in 2000.